18 Chapter 03 CALL TO ACTION

First Page		Document Content
Date: 2015-03-12 01:30:44 Tobacco Medicine Passive smoking Chronic obstructive pulmonary disease Health effects of tobacco Respiratory disease Cancer Emphysema Tobacco packaging warning messages Smoking Human behavior Ethics		18 Chapter 03 CALL TO ACTION Add to Reading List Source URL: 3pk43x313ggr4cy0lh3tctjh.wpengine.netdna-cdn.com Download Document from Source Website File Size: 3,64 MB Share Document on Facebook

	Trends in COPD (Chronic Bronchitis and Emphysema): Morbidity and Mortality Please note, this report is designed for double-sided printing DocID: 1rXbZ - View Document
	BMS_2016_Inflammation_emphysema_Fibrosis_2016.pdf DocID: 1nVzq - View Document
	Pulmonx Gets FDA Nod for U.S. Trial of Emphysema Therapy IDE for Study of Zephyr® Endobronchial Valve Approved August 27, 2012, Redwood City, CA, USA, Pulmonx, an emerging leader in interventional pulmonology, announced DocID: 1lQgn - View Document
	Treatment Options Literature 1. Sciurba F et al. A randomized study of endobronchial valves for advanced emphysema. N Eng J Med 2010;363:. Felix J.F. Herth, Marc Noppen, Arschang Valipour, Sylvie Leroy,Jean-M DocID: 1lEMB - View Document
	Patient Guide PCEN12/11_01 Endobronchial Valve Treatment of Emphysema Patients DocID: 1llqd - View Document